A lot of the "yeah, but's" that I mentioned in my last piece on electron microscopy company FEI Company (NASDAQ:FEIC) have come to pass. Spending on semiconductor equipment has disappointed as major fabs like TSMC (NYSE:TSM), Intel (NASDAQ:INTC), and Samsung (OTC:SSNLF)
revise their plans, oil/gas demand has dried up, life science demand
has been consistently inconsistent, and the company lowered its
long-term revenue growth guidance during its midyear analyst day.
None of these really surprised me, particularly the guidance
revision, so the impact to my valuation wasn't too extreme. There's
still ongoing risk to the quarterly results given the uncertainty in
semiconductor industry spending, but the valuation is pretty interesting
for a market leader with multiple growth drivers. There's still a risk
that the company's margin targets prove too ambitious, but at around 15%
below my fair value, it's worth a closer look.
Read the full article here:
Semiconductor Spending Looms Large For FEI
No comments:
Post a Comment